K. Tikhomirova, A. Anisimov, A. Khoroshutin
FULL PAPER
-OCH2-), 3.86 (m, 2 H, -OCH2-), 3.90 (m, 2 H, -OCH2-), 4.03 (m,
7.1 Hz, -OCH2CH3 of 2bII), 1.41 [m, J = 7.1 Hz, -OCH2CH3 and
2 H, -OCH2-), 4.11 (m, 2 H, -OCH2-), 4.23 (q, J = 7.1 Hz, 4 H, -CH2(CH2)2CH2- of 2bI], 1.56–1.64 [m, -CH2(CH2)2CH2- of 2bI
-OCH2CH3), 5.28 (s, 1 H, CH), 6.60 (m, 2 H, ArH), 6.79 (d, J =
8.8 Hz, 1 H, ArH), 8.32 (br. s, 2 H, NH) ppm. 13C NMR (CDCl3,
100 MHz): δ = 14.52, 21.21, 23.08, 23.28, 40.51, 59.71, 68.54, 68.62,
and 2bII], 2.01 [m, -CH2(CH2)2CH2- of 2bII], 2.70 [m, -CH2-
(CH2)2CH2- of 2bI], 2.80 [m, -CH2(CH2)2CH2- of 2bII], 3.79 (s,
-OCH3 of 2bII), 3.85 (s, -OCH3 of 2bI), 3.88 (s, -OCH3 of 2bII),
69.05, 69.13, 70.18, 70.60, 113.76, 113.82, 116.54, 119.62, 121.15, 3.95 (s, -OCH3 of 2bI), 4.25 (q, J = 7.1 Hz, -OCH2CH3 of 2bII),
129.38, 130.65, 131.82, 147.90, 148.92, 161.63 ppm. LDI-TOF: m/z 4.38 (q, J = 7.1 Hz, -OCH2CH3 of 2bI), 6.74–6.76 (m, ArH of 2bI
= 663.14 [M – H]+, 687.13 [M + Na]+. C37H48N2O9 (664.79): calcd.
C 66.85, H 7.28, N 4.21; found C 66.61, H 7.15, N 4.10.
and 2bII), 6.81–6.83 (m, ArH of 2bI and 2bII), 6.92 (m, ArH of
2bI and 2bII), 8.71 (br. s, NH of 2bII), 12.73 (br. s, NH of 2bI) ppm.
13C NMR (CDCl3, 100 MHz): δ (mixture of isomers 2bI and 2bII
in a 7:1 ratio) = 14.33, 22.38, 23.07, 23.15, 24.36, 55.83, 56.05,
60.54, 111.12, 111.96, 121.84, 129.26, 132.97, 139.21, 139.48,
141.59, 144.21, 149.28, 149.86, 162.27 ppm (signals of isomer I only
observed in 13C NMR spectrum if the conformer ratio is higher
than 6:1). 13C NMR (CDCl3, 100 MHz): δ (mixture of isomers 2bI
and 2bII in a 3:1 ratio) = 14.33, 14.42, 21.92, 22.38, 22.93, 23.07,
23.15, 23.21, 23.34, 24.36, 55.79, 55.81, 55.83, 56.05, 59.81, 60.54,
110.08, 110.59, 111.12, 111.96, 116.09, 119.44, 119.69, 121.84,
128.77, 128.82, 129.26, 132.97, 133.16, 134.51, 139.21, 139.48,
141.59, 144.21, 148.86, 148.92, 149.28, 149.86, 161.69, 162.27 ppm.
Rf = 0.9 (2bI), 0.3 (2bII) (CHCl3, Al2O3). LDI-TOF: m/z = 533.04
[M + H]+, 555.01 [M + Na]+, 570.97 [M + K]+. C31H36N2O6
(532.63): calcd. C 69.90, H 6.81, N 5.26; found C 69.74, H 6.89, N
4.85.
General Method for the Preparation of the Dipyrrins: The dipyrro-
methane (1 equiv.) was dissolved in anhydrous THF and degassed
with a stream of Ar for 20 min. A solution of DDQ (2 equiv.) in
anhydrous THF was then added by using a syringe. The solution
was stirred under Ar at room temperature for 2 h, then the reaction
mixture was diluted with CH2Cl2, washed with 10 % aqueous
Na2SO3, 10% aqueous Na2CO3, water, and brine. The organic layer
was separated, dried with Na2SO4, and the solvents were evapo-
rated to dryness.
Ethyl 1-{[3-(Ethoxycarbonyl)-4,5,6,7-tetrahydro-2H-isoindol-1-yl]-
(phenyl)methylene}-4,5,6,7-tetrahydro-1H-isoindole-3-carboxylate
(2a): Compound 4a (0.100 g, 0.211 mmol) in THF (10 mL) and
DDQ (0.0958 g, 0.422 mmol) in THF (2 mL) were reacted accord-
ing to the general procedure for 3 h,giving mixture of 2aI, 2aII,
and the initial 4a in a ratio of 9:1:1 according to NMR spec-
troscopy. After washing with hexane (50 mL), a mixture of 2aI,
2aII (0.062 g, 0.13 mmol, 62%) was isolated as an orange powder.
1H NMR (CDCl3, 400 MHz): δ (mixture of isomers 2aI and 2aII
in a ratio of 12:1; integral intensities are given for the conformers
that were observed in more than 10:1 excess) = 1.35 [m, 4 H,
-CH2(CH2)2CH2- of 2aI], 1.41 (t, J = 7.0 Hz, 6 H, -OCH2CH3 of
2aI), 1.49–1.52 [m, 4 H, -CH2(CH2)2CH2- of 2aI], 1.52–1.59 [m, 4
H, -CH2(CH2)2CH2- of 2aI], 2.68 [m, 4 H, -CH2(CH2)2CH2- of
2aI], 4.38 (q, J = 7.0 Hz, 4 H, -OCH2CH3 of 2aI), 7.24–7.27 (m, 2
H, ArH of 2aI), 7.43–7.45 (m, 3 H, ArH of 2aI), 8.69 (br. s., 1 H*,
NH of 2aII), 13.06 (br. s, 1 H*, NH of 2aI) ppm. [* Integral inten-
sities of the exchanging protons make up 0.6–0.8 of the theoretical
value.] 1H NMR (CDCl3, 400 MHz): δ (mixture of isomers 2aI and
2aII in a ratio of 2:1) = 1.30 (t, J = 7.0 Hz, -OCH2CH3 of 2aII),
1.35 [m, -CH2(CH2)2CH2- of 2aI], 1.41 (t, J = 7.0 Hz, -OCH2CH3
of 2aI), 1.49–1.52 [m, -CH2(CH2)2CH2- of 2aI], 1.53–1.59 [m,
-CH2(CH2)2CH2- of 2aI and 2aII], 1.66 [m, -CH2(CH2)2CH2- of
2aII], 1.96 [m, -CH2(CH2)2CH2- of 2aII], 2.68 [m, -CH2-
(CH2)2CH2- of 2aI], 2.79 [m, -CH2(CH2)2CH2- of 2aII], 4.24 (q, J
= 7.0 Hz, -OCH2CH3 of 2aII), 4.38 (q, J = 7.0 Hz, -OCH2CH3 of
2aI), 7.24–7.27 (m, ArH of 2aI), 7.28–7.30 (m, ArH of 2aII), 7.34–
7.36 (m, ArH of 2aII), 7.43–7.45 (m, ArH of 2aI), 8.70 (br. s, NH
of 2aII), 13.02 (br. s, NH of 2aI) ppm. 13C NMR (CDCl3,
100 MHz): δ (mixture of isomers 2aI and 2aII in a 5:1 ratio) =
14.39, 14.49, 22.07, 22.37, 22.97, 23.09, 23.18, 23.23, 23.35, 24.25,
59.80, 60.56, 116.36, 119.75, 126.85, 128.43, 128.65, 128.71, 128.80,
129.06, 129.55, 132.66, 133.02, 137.05, 139.09, 139.62, 141.82,
142.01, 144.17, 161.55, 162.32 ppm. Rf = 0.74 (2aI), 0.26 (2aII)
(CHCl3/EtOH = 50:1; SiO2). LDI-TOF: m/z = 472.99 [M + H]+,
510.91 [M + K]+. C29H32N2O4 (472.24): calcd. C 73.70, H 6.83, N
5.93; found C 73.59, H 6.88, N 5.81.
Ethyl (1Z)-1-{[3-(Ethoxycarbonyl)-4,5,6,7-tetrahydro-2H-isoindol-1-
yl](2,3,5,6,8,9,11,12-octahydro-1,4,7,10,13-benzopentaoxacyclo-
pentadecin-15-yl)methylene}-4,5,6,7-tetrahydro-1H-isoindole-3-carb-
oxylate (2c): Compound 4c (0.300 g, 0.451 mmol) in THF (15 mL)
and DDQ (0.2048 g, 0.902 mmol) in THF (5 mL) were reacted ac-
cording to the general procedure. The product was recrystallized
1
from hexane to give 2c (0.2571 g, 86%) as a red powder. H NMR
(CDCl3, 400 MHz): δ (isomer 2cI) = 1.40 [m, J = 7.2 Hz, 10 H,
-OCH2CH3 and -CH2(CH2)2CH2-], 1.57–1.64 [m, 8 H, -CH2-
(CH2)2CH2-], 2.68 [m, 4 H, -CH2(CH2)2CH2-], 3.78–3.80 (m, 8 H,
-OCH2-), 3.90 (m, 2 H, -OCH2-), 3.96 (m, 2 H, -OCH2-), 4.09 (m,
2 H, -OCH2-), 4.19 (m, 2 H, -OCH2-), 4.37 (q, J = 7.2 Hz, 4 H,
-OCH2CH3), 6.75 (m, J = 1.8 Hz, 1 H, ArH), 6.79 (m, J1 = 1.8, J2
= 8.1 Hz, 1 H, ArH), 6.90 (m, J = 8.1 Hz, 1 H, ArH), 12.86 (br. s,
1
1 H*, NH) ppm. H NMR (CDCl3, 400 MHz): δ (isomer 2cII) =
1.31 (t, J = 7.1 Hz, 6 H, -OCH2CH3), 1.54–1.58 [m, 4 H,
-CH2(CH2)2CH2-], 1.66 [m, 4 H, -CH2(CH2)2CH2-], 1.97 [m, 4 H,
-CH2(CH2)2CH2-], 2.79 [m, 4 H, -CH2(CH2)2CH2-], 3.74–3.75 (m,
8 H, -OCH2-), 3.86 (m, 2 H, -OCH2-), 3.90 (m, 2 H, -OCH2-), 4.03
(m, 2 H, -OCH2-), 4.12 (m, 2 H, -OCH2-), 4.25 (q, J = 7.1 Hz, 4
H, -OCH2CH3), 6.73 (m, J1 = 1.7, J2 = 8.3 Hz, 1 H, ArH), 6.80
(d, J = 8.3 Hz, 1 H, ArH), 6.87 (m, J = 1.7 Hz, 1 H, ArH), 8.70
(br. s, 1 H*, NH) ppm. [* Integral intensities of the exchanging
protons make up 0.6–0.8 of the theoretical value.] 13C NMR
(CDCl3, 100 MHz): δ (mixture of isomers 2cI and 2cII in a ratio
of 8:1) = 14.42, 22.45, 23.14, 23.22, 24.50, 60.58, 68.34, 68.85,
69.31, 70.11, 70.13, 71.01, 113.14, 114.25, 122.20, 129.67, 133.06,
139.31, 139.64, 141.73, 144.16, 149.27, 149.96, 162.39 ppm (signals
of isomer I only observed in the 13C NMR spectrum if the con-
former ratio is higher than 6:1). 13C NMR (CDCl3, 100 MHz,
–20 °C): δ (isomer 2cII) = 14.37, 21.57, 22.74, 23.02, 23.33, 60.05,
67.82, 67.94, 68.96, 69.01, 69.74, 70.44, 111.53, 111.59, 115.71,
119.78, 119.85, 128.76, 128.99, 132.68, 134.51, 148.31, 148.82,
161.01 ppm. Rf = 0.44 (2cI), 0.3 (2cII) (CHCl3/EtOH = 15:1; SiO2).
LDI-TOF: m/z = 663.17 [M + H]+, 685.16 [M + Na]+, 701.11 [M
+ K]+. C37H46N2O9 (662.77): calcd. C 67.05, H 7.00, N 4.23; found
C 66.76, H 6.72, N 4.32.
Ethyl (1Z)-1-{(3,4-Dimethoxyphenyl)[3-(ethoxycarbonyl)-4,5,6,7-
tetrahydro-2H-isoindol-1-yl]methylene}-4,5,6,7-tetrahydro-1H-isoind-
ole-3-carboxylate (2b): Compound 4b (0.300 g, 0.561 mmol) in
THF (15 mL) and DDQ (0.2547 g, 1.122 mmol) in THF (5 mL)
were reacted according to the general procedure to give 2b
1
(0.2898 g, 97%) as a red powder. H NMR (CDCl3, 400 MHz): δ
Supporting Information (see footnote on the first page of this arti-
(mixture of isomers 2bI and 2bII in a ratio of 4:1) = 1.31 (t, J =
cle): 2D NMR spectra of the studied compounds; kinetic measure-
2206
www.eurjoc.org
© 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2012, 2201–2207